“The idea that Aquablation [treats] any size and any shape of prostate really does seem to hold true for these cohorts of patients,” says Dean Elterman, MD, MSc, FRCSC.
In this video, Dean Elterman, MD, MSc, FRCSC, discusses how Aquablation has revolutionized the ways in which urologists perform procedures and how those procedures result in improved urinary function and quality of life for their patients. Elterman is an associate professor of urology at University of Toronto and an attending urologist at the University Health Network, Toronto, Canada.
Subcutaneous nivolumab meets coprimary pharmacokinetic end points for ccRCC
January 30th 2024Patients in the subcutaneous arm (n = 242) achieved a geometric mean Cavgd28 of 77.373μl/mL (90% CI, 74.555-80.297) compared with 36.875 μl/mL (90% CI, 35.565-38.235) in the IV arm (n = 245), for a geometric mean ratio of 2.098 μl/mL (90% CI, 2.001-2.200).